Abstract
Background
Because of the rearrangement of the gastrointestinal tract, biliopancreatic diversion (BPD) could lead to an increased risk of colorectal cancer caused by possible carcinogenetic action of the unabsorbed food and bile acid on colonic mucosa.
Methods
The incidence of colorectal cancer in 1,898 obese subjects submitted to BPD from May 76 to July 2002 with a minimum follow-up of 5 years was retrospectively evaluated.
Results
Among 28,811 person-years, seven cases of colorectal cancer were detected, for an overall incidence of 29.4 per 100,000, which is not different from that observed in the general Italian population, and lower than that reported for obese and type 2 diabetes patients. Logistic regression model suggests that occurrence of colorectal cancer is positively related to the time elapsed from BPD.
Conclusion
This study indicates that BPD does not carry any increased risk for colorectal cancer. The complete postoperative restoration of insulin sensibility could exert a valuable protective action.
Similar content being viewed by others
References
Potter JD. Nutrition and colorectal cancer. Cancer Causes Control 1996;7:127–46.
Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal cancer. Ann Rev Nutr 1999;19:545–86.
Martinez ME, Giovannucci E. Diet and the prevention of cancer. Cancer Metastasis Rev 1997;16:357–76.
Harris DM, Go VL. Vitamin D and colon carcinogenesis. J Nutr 2004;134:3463S–71S.
Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomark Prev 1998;7:163–8.
Harris PJ, Ferguson LR. Dietary fibres may protect or enhance carcinogenesis. Mutat Res 1999;443:95–110.
Chaplin MF. Bile acids, fibre and colon cancer: the story unfolds. J R Soc Health 1998;118:53–61.
Debruyne PR, Bruyneel EA, Li X, Zimber A, Gespach C, Mareel MM. The role of bile acids in carcinogenesis. Mutat Res 2001;480–481:359–69.
Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg 1998;22:936–46.
Scopinaro N, Gianetta E, Civalleri D, et al. Biliopancreatic bypass. In: Griffen WO, Printen KJ, editors. Surgical management of obesity. Marcel Decker: New York and Basel; 1987. p. 93–161.
Moore LL, Bradlee ML, Singer MR, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study. Int J Obes Relat Metab Disord 2004;28:559–67.
MacInnis RJ, English DR, Hopper JL, et al. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomark Prev 2004;13:553–9.
Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007;132:2208–25.
Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86:556–65.
Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N. Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity. Int J Obes Relat Metab Disord 2004;28:671–3.
Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006;55:2025–31.
Capocaccia R, De Angelis R, Frova L, et al. Estimation and projections of colorectal cancer trends in Italy. Int J Epidemiol 1997;26:924–32.
Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:542–7.
Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99–166.
Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza MI, Paci E; EUROPREVAL Working Group. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 2002;13:1128–39.
Ponz de Leon M, Marino M, Benatti P, et al. Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol 2004;15:940–6.
Adami GF, Papadia FS, Scopinaro N. Colorectal cancer after biliopancreatic diversion for obesity. Int J Obes (Lond) 2007 Dec;31(12):1864. Epub 2007 Jun 19.
Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 2005;3:587–94.
Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998;147:816–25.
Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164–79.
Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S–20S.
McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev 1994;3:687–95.
Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005;28(10):2406–11.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adami, G.F., Papadia, F.S., Marinari, G.M. et al. Does Biliopancreatic Diversion Carry Increased Risk for Colorectal Cancer? A Cohort Study. OBES SURG 18, 212–215 (2008). https://doi.org/10.1007/s11695-007-9348-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-007-9348-z